Serum MicroRNA Profiling and Bioinformatics of Patients with Spleen-Deficiency Syndrome

Table 2

KEGG pathways from 11 candidate serum miRNAs of SDS patients.

Term	Term ID	Targets in the term	miRNAs in the term	value
Insulin signaling pathway	hsa04910	4	8	0.0090
ErbB signaling pathway	hsa04012	3	7	0.0150
Chemokine signaling pathway	hsa04062	4	7	0.0240
Endocytosis	hsa04144	4	6	0.0286
Calcium signaling pathway	hsa04020	4	5	0.0198
Carbohydrate digestion and absorption	hsa04973	2	5	0.0270
Ubiquitin mediated proteolysis	hsa04120	3	5	0.0421
Bacterial invasion of epithelial cells	hsa05100	4	4	0.0009
FcγR-mediated phagocytosis	hsa04666	3	4	0.0181
Arginine and proline metabolism	hsa00330	2	4	0.0400
Galactose metabolism	hsa00052	2	3	0.0108
Amino sugar and nucleotide sugar metabolism	hsa00520	2	3	0.0315
Starch and sucrose metabolism	hsa00500	2	3	0.0387
Pathogenic Escherichia coli infection	hsa05130	3	2	0.0047
Valine, leucine, and isoleucine degradation	hsa00280	2	2	0.0281
Type II diabetes mellitus	hsa04930	2	2	0.0315
Shigellosis	hsa05131	2	2	0.0489
Fatty acid metabolism	hsa00071	3	1	0.0023